Orca Bio is a late-stage biotechnology company developing high-precision cell therapies for the treatment of blood cancer and autoimmune diseases. Our investigational products are designed to replace a patient’s diseased blood and immune system with a healthy one. Our manufacturing platform uses single-cell precision to create proprietary, uniquely-defined products that have the potential to revolutionize allogeneic cell therapy. Our team of leading scientists, engineers and clinicians is united in our mission to transform the lives of patients. Together, we are working to deliver the promise of a cure, without the compromise. Please note, a member of the Orca Bio team will only ever communicate using an @orcabio.com email address.
| Website | http://www.orcabio.com/ |
| Revenue | $13.1 million |
| Employees | 384 (287 on RocketReach) |
| Founded | 2016 |
| Address | 3475 Edison Way Suite B, Menlo Park, California 94025, US |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Cell Therapy, Cancer Treatment, Autoimmune Disease Treatment, Biotechnology, Immunotherapy, Blood Disease Treatment, Regenerative Medicine, Advanced Cell Therapies, Disease Treatment, Biopharmaceutical, Drug Development, Clinical Stage Biotech, Pharmaceutical Research, Biotech Research |
| Competitors | Roche, Thermo Fisher Scientific, BD, Agilent Technologies, Illumina, MilliporeSigma, Bio-Rad Laboratories, QIAGEN +37 more (view full list) |
Looking for a particular Orca Biosystems employee's phone or email?
The Orca Biosystems annual revenue was $13.1 million in 2026.
Nathaniel Fernhoff is the Chief Executive Officer and Co-founder of Orca Biosystems.
287 people are employed at Orca Biosystems.
Orca Biosystems is based in Menlo Park, California.